Octave’s Precision Care Solution Aims to Better Tailor MS Treatment
Octave announced the commercial availability of a multiple sclerosis (MS) care program that examines various facets of…
Articles by Vanda Pinto, PhD
IFN-beta Therapy Found to Help Blood Vessels in Brain Dilate in MS
Treatment with interferon beta (IFN-beta) — a disease-modifying therapy that lowers inflammation in multiple sclerosis (MS) — was…
Prexasertib’s Protective Effects Seen in Models of Neurodegeneration
Prexasertib, a small molecule inhibitor that’s been tested in clinical trials for cancer, may represent a new strategy for treating…
H. Pylori Infection May Increase MS Risk But More Studies Are Needed
Infection with the stomach bacterium Helicobacter pylori (H. pylori) does not appear to protect against the development of multiple…
Higher Levels of MS Fatigue Linked to Poorer Cognitive Skills
People with multiple sclerosis (MS) who report higher levels of fatigue are more likely to have lower performance scores…
Higher, Possibly Damaging, Zinc Levels Seen in Blood of MS Patients
People with multiple sclerosis (MS) have significantly higher and potentially damaging blood levels of zinc and a greater activity…
‘Brain Healthy Lifestyle’ May Help Prevent Disability Progression
Leading a healthy cognitive and physically active lifestyle, including having a normal body weight and well-controlled blood pressure, may increase…
Accessible NfL Blood Test Developed for Neurodegenerative Conditions
Labcorp has launched a widely accessible test that measures the levels of neurofilament light chain (NfL), a biomarker of…
Pandemic’s Negative Aspects Tied to Worse Disability in MS Patients
Worsening disability was associated with worry about COVID-19 in people with multiple sclerosis (MS) living in the U.S. and…
Final Data Likely Soon in Phase 2 Trial of Temelimab for Relapsing MS
A Phase 2 clinical trial into the safety and tolerability of higher-dose temelimab as a potential therapy for relapsing forms…
Study: Trigeminal Neuralgia Affects More Than 3% of Patients
Trigeminal neuralgia, a chronic pain condition characterized by shocks or burning sensations in the face, seems to be much…
Protxx, University Join to Study Sensor in Identifying MS Biomarkers
Protxx and the University of Victoria are partnering to explore digital biomarkers for multiple sclerosis (MS) that…
NIH Grant Boosts Delpor’s Plans for Tizanidine Implant
The development of Delpor‘s DLP-208 implant for the treatment of moderate-to-severe spasticity, a symptom that commonly affects people with…
1st Patient Enters ProTEct-MS Extension Trial Testing Higher Temelimab Doses
The first patient who completed the ProTEct-MS Phase 2 clinical trial assessing temelimab as a treatment for relapsing forms of…
MS Australia Joins Jean Hailes’ Women’s Health Week
MS Australia is again teaming up with Jean Hailes‘ Women’s Health Week, to promote good health for all…
Study Cites Factors Linked to Treatment Adherence
People with multiple sclerosis (MS) who experienced relapses in the previous year are more likely to have better adherence…
BelongMS App Now Includes French Language Option
Belong.Life, a developer of a networking platforms that help patients navigate and manage their disease, has added a French…
Fatigue Prevalence Remains High in MS Patients
The prevalence of fatigue continues to be high among people with multiple sclerosis (MS) despite significant progress over…
Phase 4 Trial Will Test if Ocrevus Can Prevent MS Onset in RIS Patients
Yale University is launching CELLO, a multicenter study to investigate the efficacy of Ocrevus (ocrelizumab) in treating people…
Tecfidera Approved in China to Treat Relapsing MS
Tecfidera (dimethyl fumarate) was given the green light by health regulators in China to treat people with relapsing multiple…
Retinal Layer Thickness May Predict MS Progression, Relapses
Measurements of the thickness of the eye’s retina — the layer of nerve cells lining the back of the eye…
NurOwn Cell Therapy Found Safe, Effective for Progressive MS in Phase 2 Trial
NurOwn cell therapy led to significant improvements in the physical abilities, vision, and cognition of people with progressive multiple…
Early MRI Findings May Predict Disease Worsening in Children with MS
Abnormalities detected on MRI scans at the onset and within the first two years of disease may predict disability worsening…
47% Rise Seen in US Medicare Payments for MS and Like Therapies, 2013-17
The cost of medications for multiple sclerosis (MS)Â and other neurologic disorders saw a sharp rise between 2013 and 2017…
Rising Temperatures Could Lead to Greater Care Needs for MS Patients
Rising average temperatures may lead to a worsening of symptoms in people with multiple sclerosis (MS) and a greater…